Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

11/11/2019 06:30

Nov 11 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.84                8.43             17.40    
                 (+4.8 pct)          (-3.3 pct)       (+2.0 pct)  
  Operating        492 mln             318 mln          824 mln   
                 (+54.7 pct)         (-37.5 pct)      (+1.1 pct)  
  Recurring        508 mln             330 mln          845 mln   
                 (+53.8 pct)         (-36.8 pct)      (+4.0 pct)  
  Net              326 mln             206 mln          552 mln   
                 (+57.7 pct)         (-40.3 pct)      (+5.6 pct)  
  EPS             95.25 yen           60.05 yen       161.45 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T